Update on Cancer Drug Nilotinib for Parkinson's Disease

This is an archived file of a live webcast that took place on August 2, 2016.

In this webinar, clinicians, researchers and a patient share the current state of science and safety around the cancer drug nilotinib for the treatment of Parkinson's disease. Our panel also discuss plans for future testing.

Title: Update on Cancer Drug Nilotinib for Parkinson's Disease

Duration: 1 hour

Continuing Medical Education Information for Health Care Professionals

MJFF is not offering CME credit for this webinar. Visit www.michaeljfox.org/webinars for our library of CME-accredited Third Thursdays webinars.

Register

Already Registered?

*Required Fields.

You must have Javascript and Cookies enabled to access this webcast. Click here for Help.

By registering you agree to receive email updates from
The Michael J. Fox Foundation. You can unsubscribe any time.